Medikaloka Hermina Tbk PT
IDX:HEAL
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 070
1 595
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one HEAL stock under the Base Case scenario is 1 284.18 IDR. Compared to the current market price of 1 395 IDR, Medikaloka Hermina Tbk PT is Overvalued by 8%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Medikaloka Hermina Tbk PT
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for HEAL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Medikaloka Hermina Tbk PT
Balance Sheet Decomposition
Medikaloka Hermina Tbk PT
Current Assets | 2T |
Cash & Short-Term Investments | 672.3B |
Receivables | 1.2T |
Other Current Assets | 141.2B |
Non-Current Assets | 8.2T |
PP&E | 7.8T |
Other Non-Current Assets | 351.5B |
Current Liabilities | 1.6T |
Accounts Payable | 354.3B |
Accrued Liabilities | 191.4B |
Short-Term Debt | 55.2B |
Other Current Liabilities | 1T |
Non-Current Liabilities | 4.2T |
Long-Term Debt | 2.7T |
Other Non-Current Liabilities | 1.5T |
Earnings Waterfall
Medikaloka Hermina Tbk PT
Revenue
|
6.6T
IDR
|
Cost of Revenue
|
-4.2T
IDR
|
Gross Profit
|
2.4T
IDR
|
Operating Expenses
|
-1.4T
IDR
|
Operating Income
|
1T
IDR
|
Other Expenses
|
-487.9B
IDR
|
Net Income
|
556.7B
IDR
|
Free Cash Flow Analysis
Medikaloka Hermina Tbk PT
IDR | |
Free Cash Flow | IDR |
HEAL Profitability Score
Profitability Due Diligence
Medikaloka Hermina Tbk PT's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Medikaloka Hermina Tbk PT's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
HEAL Solvency Score
Solvency Due Diligence
Medikaloka Hermina Tbk PT's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
Medikaloka Hermina Tbk PT's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HEAL Price Targets Summary
Medikaloka Hermina Tbk PT
According to Wall Street analysts, the average 1-year price target for HEAL is 1 794.07 IDR with a low forecast of 1 414 IDR and a high forecast of 2 100 IDR.
Dividends
Current shareholder yield for HEAL is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
PT Medikaloka Hermina engages in healthcare services. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 15,086 full-time employees. The company went IPO on 2018-05-16. The firm is focused on providing services for BPJS patients to support government program in Indonesia. The Company’s services include hospitals, specialties and featured services. The Company’s hospitals include Hermina Arcamanik, Hermina Balikpapan, Hermina Banyumanik, Hermina Bekasi, Hermina Bitung, Hermina Bogor, Hermina Ciledug, Hermina Cilegon and Hermina Ciputat. In specialties service, the Company provides anatomical pathology, andrology, anesthesiology, cardiology, clinical microbiology, clinical pathology, dentistry, dermatology and venereology, dietetics, emergency medicine, forensic and medicolegal, internal medicine, medical acupuncture, neurology and surgery. The Company’s subsidiaries include PT Medikaloka Internusa (M Internusa), PT Medikaloka Sejahtera (M Sejahtera), PT Medikaloka Husada (M Husada), PT Medikaloka Daan Mogot and PT Medikaloka Pasteur (M Pasteur).
Contact
IPO
Employees
Officers
The intrinsic value of one HEAL stock under the Base Case scenario is 1 284.18 IDR.
Compared to the current market price of 1 395 IDR, Medikaloka Hermina Tbk PT is Overvalued by 8%.